Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
International Immunology|June 24, 2008
Identification and functional validation of MHC class I epitopes in the tumor-associated antigen 5T4William H Shingler, Priscilla Chikoti, Susan M Kingsman, et al.Antimicrobial Agents and Chemotherapy|April 1, 1972
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrateC H O'Callaghan, A Morris, S M Kirby, et al.Cell Death and Differentiation|April 18, 2003
CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserineA Devitt, S Pierce, C Oldreive, et al.Life Sciences|March 26, 1984
The effects of a series of capsaicin analogues on nociception and body temperature in the ratA G Hayes, A Oxford, M Reynolds, et al.Cancer Immunology, Immunotherapy : CII|June 14, 2012
Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax)Richard Harrop, Peter Treasure, Jackie de Belin, et al.Cancer Immunology, Immunotherapy : CII|March 10, 2011
MVA-5T4-induced immune responses are an early marker of efficacy in renal cancer patientsRichard Harrop, William H Shingler, Mike McDonald, et al.Journal of Translational Medicine|January 9, 2009
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinomaHoward L Kaufman, Bret Taback, William Sherman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2010
Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III studyRobert J Amato, Robert E Hawkins, Howard L Kaufman, et al.Science Advances|February 16, 2024
Tungsten-anisole complex provides 3,6-substituted cyclohexenes for highly diversified chemical librariesJustin T Weatherford-Pratt, Jeremy M Bloch, Jacob A Smith, et al.Pageof 1